| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $83M | ||
| $63M |
Buys | $100,043 | 1 | 11 |
Sells | $2,909,114 | 8 | 89 |
| LAUKIEN FRANK H | PRESIDENT & CEO | 1 | $100,043 | 0 | $0 | $100,043 |
| Friend Cynthia M | director | 0 | $0 | 1 | $113,990 | $-113,990 |
| ORNELL JOHN A | director | 0 | $0 | 1 | $243,087 | $-243,087 |
| PACKER RICHARD A | director | 0 | $0 | 1 | $243,230 | $-243,230 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. | 0 | $0 | 5 | $2.31M | $-2.31M |
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Over the last 12 months, insiders at Bruker Corporation have bought $100,043 and sold $2.91M worth of Bruker Corporation stock.
On average, over the past 5 years, insiders at Bruker Corporation have bought $2.08M and sold $21.5M worth of stock each year.
Highest buying activity among insiders over the last 12 months: LAUKIEN FRANK H (PRESIDENT & CEO) — $100,043.
The last purchase of 2,608 shares for transaction amount of $100,043 was made by LAUKIEN FRANK H (PRESIDENT & CEO) on 2025‑06‑06.
| 2026-03-13 | Sale | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | 2,000 0.0014% | $35.44 | $70,880 | +3.86% | |
| 2026-02-13 | Sale | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | 2,000 0.0013% | $36.94 | $73,880 | +0.86% | |
| 2026-01-15 | Sale | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | 2,000 0.0013% | $49.20 | $98,400 | -22.16% | |
| 2026-01-12 | Sale | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | 7,000 0.0048% | $55.00 | $385,000 | -27.67% | |
| 2026-01-05 | Sale | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | 33,843 0.0216% | $49.66 | $1.68M | -22.81% | |
| 2025-12-01 | Sale | PACKER RICHARD A | director | 5,028 0.0034% | $48.38 | $243,230 | -11.12% | |
| 2025-11-06 | Sale | ORNELL JOHN A | director | 6,233 0.0041% | $39.00 | $243,087 | +8.45% | |
| 2025-09-12 | Sale | Friend Cynthia M | director | 3,535 0.0024% | $32.25 | $113,990 | +29.00% | |
| 2025-06-06 | LAUKIEN FRANK H | PRESIDENT & CEO | 2,608 0.0017% | $38.36 | $100,043 | +2.27% | ||
| 2025-03-10 | Bures Thomas | Chief Accounting Officer | 500 0.0003% | $47.40 | $23,698 | -16.11% | ||
| 2025-02-18 | LAUKIEN FRANK H | PRESIDENT & CEO | 20,000 0.0134% | $50.92 | $1.02M | -20.59% | ||
| 2024-12-02 | Sale | PACKER RICHARD A | director | 3,350 0.0022% | $57.82 | $193,683 | -30.60% | |
| 2024-11-18 | LAUKIEN FRANK H | PRESIDENT & CEO | 100,000 0.0669% | $50.14 | $5.01M | -17.94% | ||
| 2024-08-15 | Sale | ROSENTHAL BOB | director | 4,684 0.0032% | $63.14 | $295,748 | -19.36% | |
| 2024-03-04 | Sale | Requardt Hermann Fritz | director | 15,000 0.0109% | $90.06 | $1.35M | -29.10% | |
| 2024-02-28 | Sale | Busse Falko | PRESIDENT, BIOSPIN GROUP | 28,122 0.0201% | $85.48 | $2.4M | -25.95% | |
| 2024-02-22 | Sale | Prause Burkhard | PRES. & CEO, BRUKER BEST | 15,319 0.011% | $83.30 | $1.28M | -23.29% | |
| 2023-08-08 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 37,947 0.0256% | $64.81 | $2.46M | +2.63% | |
| 2023-06-16 | Sale | Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | 14,242 0.0097% | $75.42 | $1.07M | -5.11% | |
| 2023-05-19 | Sale | Kastner Marc A | director | 11,146 0.0075% | $75.22 | $838,402 | -5.05% |
| LAUKIEN FRANK H | PRESIDENT & CEO | 38462171 25.2677% | $1.46B | 91 | 16 | +26.03% |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. | 128443 0.0844% | $4.88M | 0 | 10 | |
| PACKER RICHARD A | director | 89174 0.0586% | $3.39M | 2 | 4 | +5.57% |
| ORNELL JOHN A | director | 35212 0.0231% | $1.34M | 0 | 1 | |
| Friend Cynthia M | director | 18016 0.0118% | $684,247.68 | 0 | 8 | |
| LAUKIEN DIRK D | 15862972 10.4212% | $602.48M | 1 | 7 | ||
| LAUKIEN JOERG C | 15208795 9.9914% | $577.63M | 4 | 7 | +23.32% | |
| LAUKIEN MARC M | 10 percent owner | 14506348 9.5299% | $550.95M | 1 | 4 | |
| LAUKIEN ISOLDE | 10 percent owner | 14160160 9.3025% | $537.8M | 1 | 3 | |
| Srega Juergen | Group President Bruker CALID | 130936 0.086% | $4.97M | 0 | 1 | |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 99925 0.0656% | $3.8M | 0 | 1 | |
| KNIGHT WILLIAM J | Chief Financial Officer | 63350 0.0416% | $2.41M | 3 | 0 | +60.53% |
| KNISS RICHARD | director | 40753 0.0268% | $1.55M | 0 | 2 | |
| Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | 36462 0.024% | $1.38M | 0 | 1 | |
| Busse Falko | PRESIDENT, BIOSPIN GROUP | 32859 0.0216% | $1.25M | 0 | 1 | |
| ROSENTHAL BOB | director | 30963 0.0203% | $1.18M | 0 | 1 | |
| LINTON WILLIAM A | director | 29000 0.0191% | $1.1M | 1 | 0 | +24.9% |
| Requardt Hermann Fritz | director | 23147 0.0152% | $879,123.06 | 0 | 1 | |
| Prause Burkhard | PRES. & CEO, BRUKER BEST | 17065 0.0112% | $648,128.70 | 0 | 4 | |
| Martin Gilles Gerard Jean | director | 14657 0.0096% | $556,672.86 | 0 | 1 | |
| Lenggenhager Rene | President, BioSpin Group | 11037 0.0073% | $419,185.26 | 0 | 1 | |
| Kastner Marc A | director | 8051 0.0053% | $305,776.98 | 0 | 6 | |
| VAN INGEN CHRIS | director | 4577 0.003% | $173,834.46 | 0 | 2 | |
| Bures Thomas | Chief Accounting Officer | 3472 0.0023% | $131,866.56 | 1 | 0 | |
| STEIN RICHARD M | Secretary | 3349 0.0022% | $127,195.02 | 0 | 2 | |
| FURLONG BRENDA J | director | 1000 0.0007% | $37,980.00 | 0 | 1 | |
| Emmerich Wolf-Dieter | director | 0 0% | $0 | 0 | 1 | |
| Fesik Stephen W. | director | 0 0% | $0 | 0 | 1 |
| Increased Positions | 202 | +48.33% | 19M | +14.61% |
| Decreased Positions | 189 | -45.22% | 17M | -12.71% |
| New Positions | 86 | New | 6M | New |
| Sold Out Positions | 66 | Sold Out | 4M | Sold Out |
| Total Postitions | 431 | +3.11% | 136M | +1.9% |
| Orbis Allan Gray Ltd | $680,539.00 | 9.31% | 14.15M | +9M | +202.38% | 2025-09-30 |
| Fmr Llc | $660,688.00 | 9.04% | 13.73M | +5M | +63.37% | 2025-09-30 |
| Blackrock, Inc. | $527,151.00 | 7.21% | 10.96M | -123,759 | -1.12% | 2025-09-30 |
| Vanguard Group Inc | $500,549.00 | 6.85% | 10.4M | -27,612 | -0.27% | 2025-09-30 |
| Pallas Capital Advisors Llc | $456,109.00 | 6.24% | 9.48M | -20,698 | -0.22% | 2025-09-30 |
| T. Rowe Price Investment Management, Inc. | $306,924.00 | 4.2% | 6.38M | -5M | -44.19% | 2025-09-30 |
| State Street Corp | $179,937.00 | 2.46% | 3.74M | -44,567 | -1.18% | 2025-09-30 |
| Edmond De Rothschild Holding S.A. | $152,351.00 | 2.08% | 3.17M | +2M | +110.32% | 2025-09-30 |
| Sculptor Capital Lp | $147,929.00 | 2.02% | 3.07M | 0 | 0% | 2025-09-30 |
| London Co Of Virginia | $144,739.00 | 1.98% | 3.01M | -1M | -25.23% | 2025-09-30 |